Coagulation Studies in 45 Cases of Nephrotic Syndrome without Uremia^[*]

Summary

Coagulation studies were performed in 45 cases of nephrotic syndrome without uremia. The most striking features were an increase in the number of thrombocytes, and in the level of fibrinogen, factor V and factor VIII. Thrombin time was usually prolonged and the titre of antithrombin III was increased. No fibrin breakdown products were found in the serum. 13 patients developed thrombotic complications, with eventual death in 5 cases.

• References

• 1 Alagille D, Soulier J. P. Le test d’activité plaquettaire du sérum. Rev. franç. Étud. clin, biol 02: 231 1957;
• 2 Alagille D, Soulier J. P. Étude du temps de thrombine chez les hépatiques. Rev. int. Hépat 07: 1 1957;
• 3 von Dittrich P, Fries R. Untersuchung einiger Gerinnungsfaktoren (Fibrinogen, Antithrombin III und Thrombelastogramm) bei Nierenkrankheiten. Klin. Wschr 43: 390 1965;
• 4 Egeberg O. Conditions associated with increased blood factor VIII activity. “The hemophilias”. International Symposium. Brinkhous K. M. ed. The University of North Carolina Press; 203.
• 5 Eisenberg S. Blood volume in persons with the nephrotic syndrome. Amer. J. med. Sci 255: 320 1968;
• 6 Fisher E. R, Sharrey D, Pardo V, Vuzevshi V. Experimental renal vein constriction. Lab. Invest 18: 689 1968;
• 7 Gouault M. Étude critique des méthodes de dorsage de la prothrombine. Dosage de la prothrombine dans le plasma et le sérum, les fractions plasmatiques et les liquides biologiques. Mise en évidence d’une anomalie de la prothrombine chez des sujets traités par les antagonistes de la vitamine K. Thèse (Médecine). Paris: 1967
• 8 Gram H. G. A new method for the determination of the fibrin percentage in blood and plasma. J. biol. Chem 49: 279 1921;
• 9 Gross R, Nieth H, Mammen E. Blutungsbereitschaft und Gerinnungsstörungen bei Urämie. Klin. Wschr 36: 107 1958;
• 10 Larrieu M. J, Weilland G. Utilisation de la “céphaline” dans les tests de coagulation. Rev. Hémat 12: 199 1957;
• 11 Morris J. F, Ginn E, Thompson D. D. Unilateral renal vein thrombosis associated with the nephrotic syndrome. Amer. J. Med 34: 867 1963;
• 12 Richet G, Gillot G, Vaysse J, Meyerovitch A. La thrombose isolée de la veine rénale. Presse méd 73: 2039 1965;
• 13 Schultz F. H. Das Fibrinogen. VEB Georg Thieme, Leipzig (1953) 73: 2035 1965;
• 14 Soulier J. P, Le Bolloch A. G. Le test de tolérance à l’héparine in vitro. Rev. Hémat 05: 148 1950;
• 15 Soulier J. P, Larrieu M. J. Étude analytique des temps de Quick allongés. Dosage de prothrombine, de proconvertine et de proaccélérine. Sang 23: 549 1952;
• 16 Soulier J. P, Larrieu M. J. Nouvelle méthode de diagnostic de l’hémophilie. Dosage des facteurs antihémophiliques A et B. Sang 24: 205 1953;
• 17 Steinbuch M, Blatrix G. h, Josso F. Action anti-protéase de l’alpha-2-macroglobuline. II. Son rôle d’antithrombine progressive. Rev. franç. Étud. clin. Biol 13: 179 1968;
• 18 Stiehm E. R, TrygstacL C. W. Splits products in human renal disease. Amer. J. Med 46: 774 1969;
• 19 Takeda Y, Chen A. Y. Fibrinogen metabolism and distribution in patients with the nephrotic syndrome. J. Lab. clin. Med 70: 678 1967;
• 20 Todd M. E. Coagulation studies in patients with the nephrotic syndrome and the uremic state. Xlth Congress of International Society of Haematology (abstract). 239 Sidney: 1966
• 21 Wardle E. N, Taylor G. Fibrin breakdown products and fibrinolysis in renal disease. J. clin. Path 21: 140 1968;
• 22 Worowski K. The hypercoagulability in mercury chloride intoxicated dogs. Thrombos. Diathes. haemorrh. (Stuttg) 19: 236 1968;
• 23 Worowski K, Niewiarowski S, Prokopowicz J. Fibrinolysis and fibrinogen breakdown products (antithrombin VI) in renal venous blood in dogs. Thrombos. Diathes. haemorrh. (Stuttg) 12: 87 1964;
• 24 Yatzidis H, Richet G. Activité de certaines protéines de la coagulation dans le plasma et les urines au cours du syndrome néphrotique. Rev. franç. Étud. clin. Biol 02: 717 1957;